25 XP   0   0   10

Taro Pharmaceutical Industries Ltd
Buy, Hold or Sell?

Let's analyse Taro together

PenkeI guess you are interested in Taro Pharmaceutical Industries Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Taro Pharmaceutical Industries Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Taro Pharmaceutical Industries Ltd

I send you an email if I find something interesting about Taro Pharmaceutical Industries Ltd.

Quick analysis of Taro (30 sec.)










What can you expect buying and holding a share of Taro? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$46.05
Expected worth in 1 year
$48.39
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$2.34
Return On Investment
5.5%

For what price can you sell your share?

Current Price per Share
$42.40
Expected price per share
$40.67 - $45.76
How sure are you?
50%

1. Valuation of Taro (5 min.)




Live pricePrice per Share (EOD)

$42.40

Intrinsic Value Per Share

$-59.80 - $22.77

Total Value Per Share

$-13.75 - $68.83

2. Growth of Taro (5 min.)




Is Taro growing?

Current yearPrevious yearGrowGrow %
How rich?$1.7b$1.7b$19.4m1.1%

How much money is Taro making?

Current yearPrevious yearGrowGrow %
Making money$25.4m$58.2m-$32.8m-129.0%
Net Profit Margin4.4%10.4%--

How much money comes from the company's main activities?

3. Financial Health of Taro (5 min.)




What can you expect buying and holding a share of Taro? (5 min.)

Welcome investor! Taro's management wants to use your money to grow the business. In return you get a share of Taro.

What can you expect buying and holding a share of Taro?

First you should know what it really means to hold a share of Taro. And how you can make/lose money.

Speculation

The Price per Share of Taro is $42.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Taro.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Taro, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $46.05. Based on the TTM, the Book Value Change Per Share is $0.58 per quarter. Based on the YOY, the Book Value Change Per Share is $1.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Taro.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.681.6%0.681.6%1.553.7%1.142.7%5.4112.8%
Usd Book Value Change Per Share0.581.4%0.581.4%1.102.6%-1.80-4.2%2.616.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%2.566.0%1.283.0%
Usd Total Gains Per Share0.581.4%0.581.4%1.102.6%0.771.8%3.909.2%
Usd Price Per Share24.32-24.32-43.26-62.12-92.13-
Price to Earnings Ratio35.92-35.92-27.95-16.24-14.80-
Price-to-Total Gains Ratio41.60-41.60-39.51-20.09-20.57-
Price to Book Ratio0.53-0.53-0.95-1.29-2.28-
Price-to-Total Gains Ratio41.60-41.60-39.51-20.09-20.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share42.4
Number of shares23
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.002.56
Usd Book Value Change Per Share0.58-1.80
Usd Total Gains Per Share0.580.77
Gains per Quarter (23 shares)13.4417.61
Gains per Year (23 shares)53.7870.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105444236-16660
2010898472-331130
30161152708-497200
40215206944-662270
502692601180-828340
603233141416-993410
703763681652-1159480
804304221888-1324550
904844762124-1490620
1005385302360-1655690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%31.01.00.096.9%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%26.06.00.081.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.09.010.0%2.00.030.06.3%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%27.05.00.084.4%

Fundamentals of Taro

About Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.

Fundamental data was last updated by Penke on 2024-04-26 13:51:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Taro Pharmaceutical Industries Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Taro earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.4% means that $0.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 4.4%. The company is making a profit. +1
  • The TTM is 4.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY10.4%-5.9%
TTM4.4%5Y4.4%+0.1%
5Y4.4%10Y26.6%-22.3%
1.1.2. Return on Assets

Shows how efficient Taro is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.2% Return on Assets means that Taro generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.2%0.0%
TTM1.2%YOY2.7%-1.5%
TTM1.2%5Y2.2%-1.0%
5Y2.2%10Y12.0%-9.8%
1.1.3. Return on Equity

Shows how efficient Taro is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.5% Return on Equity means Taro generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 1.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.5%0.0%
TTM1.5%YOY3.4%-1.9%
TTM1.5%5Y1.5%-0.1%
5Y1.5%10Y13.7%-12.2%

1.2. Operating Efficiency of Taro Pharmaceutical Industries Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Taro is operating .

  • Measures how much profit Taro makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 3.1% means the company generated $0.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 3.1%. The company is operating less efficient.
  • The TTM is 3.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.1%TTM3.1%0.0%
TTM3.1%YOY32.8%-29.8%
TTM3.1%5Y48.4%-45.3%
5Y48.4%10Y52.5%-4.2%
1.2.2. Operating Ratio

Measures how efficient Taro is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 0.969. The company is less efficient in keeping operating costs low.
  • The TTM is 0.969. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.969TTM0.9690.000
TTM0.969YOY0.777+0.192
TTM0.9695Y0.733+0.236
5Y0.73310Y0.579+0.153

1.3. Liquidity of Taro Pharmaceutical Industries Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Taro is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.47 means the company has $3.47 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 3.466. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.466. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.466TTM3.4660.000
TTM3.466YOY3.096+0.370
TTM3.4665Y4.491-1.025
5Y4.49110Y5.746-1.254
1.3.2. Quick Ratio

Measures if Taro is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 4.68 means the company can pay off $4.68 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 4.683. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.683. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.683TTM4.6830.000
TTM4.683YOY3.927+0.756
TTM4.6835Y5.676-0.993
5Y5.67610Y7.402-1.725

1.4. Solvency of Taro Pharmaceutical Industries Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Taro assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Taro to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.19 means that Taro assets are financed with 18.9% credit (debt) and the remaining percentage (100% - 18.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 0.189. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.189. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.189TTM0.1890.000
TTM0.189YOY0.214-0.024
TTM0.1895Y0.181+0.009
5Y0.18110Y0.159+0.021
1.4.2. Debt to Equity Ratio

Measures if Taro is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 23.4% means that company has $0.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The MRQ is 0.234. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.234. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.234TTM0.2340.000
TTM0.234YOY0.272-0.038
TTM0.2345Y0.230+0.004
5Y0.23010Y0.197+0.033

2. Market Valuation of Taro Pharmaceutical Industries Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Taro generates.

  • Above 15 is considered overpriced but always compare Taro to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 35.92 means the investor is paying $35.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The EOD is 62.629. Based on the earnings, the company is expensive. -2
  • The MRQ is 35.923. Based on the earnings, the company is overpriced. -1
  • The TTM is 35.923. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD62.629MRQ35.923+26.706
MRQ35.923TTM35.9230.000
TTM35.923YOY27.947+7.976
TTM35.9235Y16.235+19.688
5Y16.23510Y14.795+1.440
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The EOD is 114.623. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 65.746. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 65.746. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD114.623MRQ65.746+48.877
MRQ65.746TTM65.7460.000
TTM65.746YOY-9.537+75.283
TTM65.7465Y35.742+30.004
5Y35.74210Y25.092+10.650
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Taro is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Taro Pharmaceutical Industries Ltd:

  • The EOD is 0.921. Based on the equity, the company is cheap. +2
  • The MRQ is 0.528. Based on the equity, the company is cheap. +2
  • The TTM is 0.528. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.921MRQ0.528+0.393
MRQ0.528TTM0.5280.000
TTM0.528YOY0.951-0.423
TTM0.5285Y1.292-0.764
5Y1.29210Y2.282-0.990
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Taro Pharmaceutical Industries Ltd.

3.1. Institutions holding Taro Pharmaceutical Industries Ltd

Institutions are holding 13.42% of the shares of Taro Pharmaceutical Industries Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Krensavage Asset Management, LLC1.729.582764645357180.8924
2023-12-31BlackRock Inc1.65750.0007622983410937.062
2023-12-31Renaissance Technologies Corp1.54160.0375579400-9400-1.5965
2023-12-31Dimensional Fund Advisors, Inc.1.45190.0067545682-4226-0.7685
2023-12-31Brandes Investment Partners & Co1.26580.301747574132530.6885
2023-12-31Ameriprise Financial Inc0.81740.003830722529160.9582
2023-12-31Eversept Partners, LLC0.68110.93962559886650.2605
2023-12-31Amvescap Plc.0.62920.0024236486-28569-10.7785
2023-12-31Murchinson Ltd.0.44641.22111677826403861.7269
2023-12-31State Street Corporation0.43550.000316369335832.2378
2023-12-31Geode Capital Management, LLC0.24690.00049281343404.9055
2023-12-31Northern Trust Corp0.16520.00056208041397.1435
2023-12-31Morgan Stanley - Brokerage Accounts0.15020.00025643633446.2985
2023-12-31ARK Investment Management LLC0.1470.013755266-2295-3.9871
2023-12-31Vanguard Group Inc0.13530.00015084027885.802
2023-12-31NORGES BANK0.1140.000342835-17955-29.5361
2023-12-31Arrowstreet Capital Limited Partnership0.10520.001739556-31314-44.1851
2023-12-31UBS Group AG0.09820.000536904-17271-31.88
2023-12-31Nuveen Asset Management, LLC0.09190.0005345451294259.9083
2023-09-30Citadel Advisors Llc0.06030.000222666226660
Total 11.960612.11464495374+60455+1.3%

3.2. Funds holding Taro Pharmaceutical Industries Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28iShares Russell 2000 ETF0.52840.0128198583960.0484
2024-03-31Columbia Small Cap Value I0.38110.4074143222-56490-28.2857
2024-03-31Columbia Small Cap Value I A0.38110.3895143222-32470-18.4812
2024-03-31DSP Healthcare Fund Reg Gr0.23811.34278947500
2024-01-31Fidelity Small Cap Index0.21820.0142819956100.7495
2023-12-31Brandes International Small Cap Equity A0.21520.79548087000
2024-03-28iShares Russell 2000 Value ETF0.20860.02657841028883.8241
2024-02-29DFA US Core Equity 2 I0.20670.00997768200
2024-03-31Brandes Global Small-Mid Cap Equity0.193.19777140500
2024-03-28iShares Core MSCI EAFE ETF0.17310.00246507300
2024-02-29DFA US Core Equity 1 I0.15470.00735812600
2024-03-31Columbia VP Small Cap Value 10.14750.428955446-14520-20.7529
2024-03-31ARK Israel Innovative Technology ETF0.13421.95365044600
2024-02-29DFA US Micro Cap I0.13210.02914965700
2024-02-29DFA US Targeted Value I0.13150.01614941800
2024-02-29DFA US Small Cap I0.12060.01234532200
2024-03-31State St Russell Sm/Mid Cp® Indx NL Cl C0.10460.003939300700021.6718
2024-03-29Dimensional US Core Equity 2 ETF0.10120.00593801700
2024-03-28iShares MSCI EAFE Small-Cap ETF0.09030.01463392400
2024-03-31Brandes Global Opportunities F0.08770.93933297400
Total 3.94499.60951482567-92886-6.3%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Taro Pharmaceutical Industries Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5850.5850%1.095-47%-1.799+408%2.613-78%
Book Value Per Share--46.05246.0520%45.467+1%47.953-4%44.639+3%
Current Ratio--3.4663.4660%3.096+12%4.491-23%5.746-40%
Debt To Asset Ratio--0.1890.1890%0.214-11%0.181+5%0.159+19%
Debt To Equity Ratio--0.2340.2340%0.272-14%0.230+2%0.197+19%
Dividend Per Share----0%-0%2.565-100%1.282-100%
Eps--0.6770.6770%1.548-56%1.137-40%5.407-87%
Free Cash Flow Per Share--0.3700.3700%-4.536+1326%2.084-82%5.278-93%
Free Cash Flow To Equity Per Share--0.3700.3700%-5.198+1505%-1.336+461%2.067-82%
Gross Profit Margin---3.452-3.4520%0.028-12319%-0.100-97%0.450-867%
Intrinsic Value_10Y_max--22.775--------
Intrinsic Value_10Y_min---59.801--------
Intrinsic Value_1Y_max--4.643--------
Intrinsic Value_1Y_min---2.387--------
Intrinsic Value_3Y_max--12.150--------
Intrinsic Value_3Y_min---10.337--------
Intrinsic Value_5Y_max--17.489--------
Intrinsic Value_5Y_min---21.695--------
Market Cap1593587040.000+43%914064549.120914064549.1200%1628353423.620-44%2385713958.488-62%3780155075.257-76%
Net Profit Margin--0.0440.0440%0.104-57%0.044+2%0.266-83%
Operating Margin--0.0310.0310%0.328-91%0.484-94%0.525-94%
Operating Ratio--0.9690.9690%0.777+25%0.733+32%0.579+67%
Pb Ratio0.921+43%0.5280.5280%0.951-44%1.292-59%2.282-77%
Pe Ratio62.629+43%35.92335.9230%27.947+29%16.235+121%14.795+143%
Price Per Share42.400+43%24.32024.3200%43.260-44%62.124-61%92.126-74%
Price To Free Cash Flow Ratio114.623+43%65.74665.7460%-9.537+115%35.742+84%25.092+162%
Price To Total Gains Ratio72.535+43%41.60541.6050%39.506+5%20.093+107%20.566+102%
Quick Ratio--4.6834.6830%3.927+19%5.676-17%7.402-37%
Return On Assets--0.0120.0120%0.027-55%0.022-45%0.120-90%
Return On Equity--0.0150.0150%0.034-57%0.015-5%0.137-89%
Total Gains Per Share--0.5850.5850%1.095-47%0.766-24%3.895-85%
Usd Book Value--1730858000.0001730858000.0000%1711443000.000+1%1831727600.000-6%1781796300.000-3%
Usd Book Value Change Per Share--0.5850.5850%1.095-47%-1.799+408%2.613-78%
Usd Book Value Per Share--46.05246.0520%45.467+1%47.953-4%44.639+3%
Usd Dividend Per Share----0%-0%2.565-100%1.282-100%
Usd Eps--0.6770.6770%1.548-56%1.137-40%5.407-87%
Usd Free Cash Flow--13903000.00013903000.0000%-170737000.000+1328%81605800.000-83%219867400.000-94%
Usd Free Cash Flow Per Share--0.3700.3700%-4.536+1326%2.084-82%5.278-93%
Usd Free Cash Flow To Equity Per Share--0.3700.3700%-5.198+1505%-1.336+461%2.067-82%
Usd Market Cap1593587040.000+43%914064549.120914064549.1200%1628353423.620-44%2385713958.488-62%3780155075.257-76%
Usd Price Per Share42.400+43%24.32024.3200%43.260-44%62.124-61%92.126-74%
Usd Profit--25445000.00025445000.0000%58266000.000-56%41797800.000-39%226207100.000-89%
Usd Revenue--572952000.000572952000.0000%561347000.000+2%599586200.000-4%711221100.000-19%
Usd Total Gains Per Share--0.5850.5850%1.095-47%0.766-24%3.895-85%
 EOD+4 -4MRQTTM+0 -0YOY+16 -185Y+8 -2810Y+5 -31

4.2. Fundamental Score

Let's check the fundamental score of Taro Pharmaceutical Industries Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1562.629
Price to Book Ratio (EOD)Between0-10.921
Net Profit Margin (MRQ)Greater than00.044
Operating Margin (MRQ)Greater than00.031
Quick Ratio (MRQ)Greater than14.683
Current Ratio (MRQ)Greater than13.466
Debt to Asset Ratio (MRQ)Less than10.189
Debt to Equity Ratio (MRQ)Less than10.234
Return on Equity (MRQ)Greater than0.150.015
Return on Assets (MRQ)Greater than0.050.012
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Taro Pharmaceutical Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.981
Ma 20Greater thanMa 5042.189
Ma 50Greater thanMa 10042.128
Ma 100Greater thanMa 20041.789
OpenGreater thanClose42.340
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Other Current Assets  8,1377068,8434,04812,8911,32914,220-14,221-1



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,135,513
Total Liabilities404,655
Total Stockholder Equity1,730,858
 As reported
Total Liabilities 404,655
Total Stockholder Equity+ 1,730,858
Total Assets = 2,135,513

Assets

Total Assets2,135,513
Total Current Assets1,336,428
Long-term Assets799,085
Total Current Assets
Cash And Cash Equivalents 154,495
Short-term Investments 695,794
Net Receivables 259,470
Inventory 226,669
Total Current Assets  (as reported)1,336,428
Total Current Assets  (calculated)1,336,428
+/-0
Long-term Assets
Property Plant Equipment 190,139
Goodwill 17,231
Long Term Investments 404,896
Intangible Assets 76,144
Long-term Assets Other 83,147
Long-term Assets  (as reported)799,085
Long-term Assets  (calculated)771,557
+/- 27,528

Liabilities & Shareholders' Equity

Total Current Liabilities385,549
Long-term Liabilities19,106
Total Stockholder Equity1,730,858
Total Current Liabilities
Short-term Debt 1,950
Accounts payable 68,485
Other Current Liabilities 314,211
Total Current Liabilities  (as reported)385,549
Total Current Liabilities  (calculated)384,646
+/- 903
Long-term Liabilities
Capital Lease Obligations 1,950
Long-term Liabilities Other 2,655
Long-term Liabilities  (as reported)19,106
Long-term Liabilities  (calculated)4,605
+/- 14,501
Total Stockholder Equity
Common Stock680
Retained Earnings 2,414,136
Accumulated Other Comprehensive Income -174,996
Other Stockholders Equity -508,962
Total Stockholder Equity (as reported)1,730,858
Total Stockholder Equity (calculated)1,730,858
+/-0
Other
Capital Stock680
Cash and Short Term Investments 850,289
Common Stock Shares Outstanding 37,585
Current Deferred Revenue903
Liabilities and Stockholders Equity 2,135,513
Net Debt -152,545
Net Invested Capital 1,730,858
Net Working Capital 950,879
Property Plant and Equipment Gross 525,589
Short Long Term Debt Total 1,950



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-311999-03-311998-03-311997-03-311996-03-311995-03-311994-03-311993-03-311992-03-311991-03-311990-03-311989-03-311988-03-31
> Total Assets 
7,300
7,900
9,600
11,200
14,700
25,600
33,800
42,800
49,500
61,900
73,100
74,600
90,957
120,446
307,762
379,845
616,523
696,847
548,200
579,011
483,400
473,100
424,690
483,353
795,845
1,106,636
1,284,376
1,737,745
2,188,033
2,289,753
2,433,210
2,135,326
2,341,252
2,406,873
2,176,361
2,135,513
2,135,5132,176,3612,406,8732,341,2522,135,3262,433,2102,289,7532,188,0331,737,7451,284,3761,106,636795,845483,353424,690473,100483,400579,011548,200696,847616,523379,845307,762120,44690,95774,60073,10061,90049,50042,80033,80025,60014,70011,2009,6007,9007,300
   > Total Current Assets 
4,500
4,700
5,600
7,000
10,100
15,100
17,700
25,000
27,900
33,000
38,900
39,700
50,725
71,738
231,494
257,115
383,693
333,114
197,500
221,698
208,400
226,600
133,397
208,421
581,431
909,771
1,051,271
1,513,807
1,877,595
1,999,024
1,896,635
1,482,720
1,532,598
1,470,835
1,337,886
1,336,428
1,336,4281,337,8861,470,8351,532,5981,482,7201,896,6351,999,0241,877,5951,513,8071,051,271909,771581,431208,421133,397226,600208,400221,698197,500333,114383,693257,115231,49471,73850,72539,70038,90033,00027,90025,00017,70015,10010,1007,0005,6004,7004,500
       Cash And Cash Equivalents 
900
100
700
300
600
200
1,300
1,300
800
600
800
1,100
3,003
7,245
153,148
130,717
159,121
98,630
72,800
72,828
45,200
68,800
16,140
45,187
239,815
237,284
209,967
481,641
576,757
600,399
576,611
567,451
513,354
605,177
251,134
154,495
154,495251,134605,177513,354567,451576,611600,399576,757481,641209,967237,284239,81545,18716,14068,80045,20072,82872,80098,630159,121130,717153,1487,2453,0031,1008006008001,3001,300200600300700100900
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,307
2,416
2,468
2,518
13,300
100
100
0
10,000
114
10,000
2,901
315,786
422,201
438,357
651,869
786,361
846,009
481,883
595,383
418,480
569,614
695,794
695,794569,614418,480595,383481,883846,009786,361651,869438,357422,201315,7862,90110,00011410,000010010013,3002,5182,4682,4162,3070000000000000
       Net Receivables 
1,800
2,600
2,600
4,100
5,900
7,600
9,100
13,300
14,200
17,400
21,400
21,900
27,405
40,490
49,265
69,038
120,522
124,674
40,600
65,819
87,300
71,600
55,149
96,277
215,176
239,578
301,164
473,338
509,335
470,204
329,420
285,307
270,788
266,886
306,699
259,470
259,470306,699266,886270,788285,307329,420470,204509,335473,338301,164239,578215,17696,27755,14971,60087,30065,81940,600124,674120,52269,03849,26540,49027,40521,90021,40017,40014,20013,3009,1007,6005,9004,1002,6002,6001,800
       Inventory 
1,800
2,000
2,300
2,600
3,700
5,700
5,800
8,700
11,200
13,100
14,800
14,700
18,208
19,618
29,081
42,439
84,486
86,591
60,300
76,192
67,000
66,100
56,762
66,957
107,378
109,626
117,639
120,272
138,553
141,045
144,595
148,079
153,073
180,292
210,439
226,669
226,669210,439180,292153,073148,079144,595141,045138,553120,272117,639109,626107,37866,95756,76266,10067,00076,19260,30086,59184,48642,43929,08119,61818,20814,70014,80013,10011,2008,7005,8005,7003,7002,6002,3002,0001,800
   > Long-term Assets 
2,800
3,200
4,000
4,200
4,600
10,500
16,100
17,800
21,600
28,900
34,200
34,900
40,232
48,708
76,268
122,730
232,830
363,733
0
357,313
0
0
291,293
274,932
214,414
196,865
233,105
223,938
310,438
290,729
536,575
652,606
808,654
936,038
838,475
799,085
799,085838,475936,038808,654652,606536,575290,729310,438223,938233,105196,865214,414274,932291,29300357,3130363,733232,830122,73076,26848,70840,23234,90034,20028,90021,60017,80016,10010,5004,6004,2004,0003,2002,800
       Property Plant Equipment 
2,000
2,400
2,500
2,900
3,600
9,400
11,100
13,000
16,200
23,700
28,700
29,600
34,624
41,827
54,024
93,358
182,306
241,966
269,419
269,419
211,929
186,543
219,753
211,929
152,532
145,265
151,416
153,045
159,459
180,085
193,727
206,242
209,961
205,508
199,692
190,139
190,139199,692205,508209,961206,242193,727180,085159,459153,045151,416145,265152,532211,929219,753186,543211,929269,419269,419241,966182,30693,35854,02441,82734,62429,60028,70023,70016,20013,00011,1009,4003,6002,9002,5002,4002,000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
4,400
4,300
4,200
4,000
3,800
7,200
7,200
7,200
7,200
7,232
7,300
7,200
7,231
7,287
7,277
7,277
7,248
7,206
7,198
7,192
7,201
7,191
7,191
7,191
11,820
17,231
17,23111,8207,1917,1917,1917,2017,1927,1987,2067,2487,2777,2777,2877,2317,2007,3007,2327,2007,2007,2007,2003,8004,0004,2004,3004,4000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,894
30,175
115,173
70,685
225,639
304,322
459,639
557,209
435,189
404,896
404,896435,189557,209459,639304,322225,63970,685115,17330,17552,89400000000000000000000000000
       Intangible Assets 
700
700
700
700
0
0
0
0
0
0
100
0
0
4,885
2,400
14,826
37,386
70,396
59,000
59,000
26,400
23,800
28,643
26,368
19,172
15,595
16,614
13,204
22,372
19,867
20,801
22,332
21,662
19,786
60,124
76,144
76,14460,12419,78621,66222,33220,80119,86722,37213,20416,61415,59519,17226,36828,64323,80026,40059,00059,00070,39637,38614,8262,4004,88500100000000700700700700
       Long-term Assets Other 
100
100
800
600
1,000
1,100
5,000
4,800
5,400
5,200
5,500
5,300
5,608
847
-6,323
1,348
2,888
19,984
3,100
60,673
2,800
1,100
31,543
26,576
38,751
23,106
52,869
46,291
2,229
2,576
1,950
1,545
3,508
4,337
6,768
83,147
83,1476,7684,3373,5081,5451,9502,5762,22946,29152,86923,10638,75126,57631,5431,1002,80060,6733,10019,9842,8881,348-6,3238475,6085,3005,5005,2005,4004,8005,0001,1001,000600800100100
> Total Liabilities 
5,800
6,400
7,500
9,300
9,400
15,100
16,200
20,900
25,400
35,500
45,700
45,700
50,257
70,064
88,622
109,549
267,412
328,033
420,100
342,146
330,100
308,900
374,907
330,115
224,782
215,675
263,783
320,362
250,889
215,947
222,811
224,204
231,494
711,416
464,918
404,655
404,655464,918711,416231,494224,204222,811215,947250,889320,362263,783215,675224,782330,115374,907308,900330,100342,146420,100328,033267,412109,54988,62270,06450,25745,70045,70035,50025,40020,90016,20015,1009,4009,3007,5006,4005,800
   > Total Current Liabilities 
2,700
2,900
4,100
5,700
6,800
11,100
13,500
18,900
13,500
20,200
28,500
27,800
24,761
28,150
34,783
58,244
103,738
131,529
250,400
170,285
232,900
239,400
263,579
232,869
190,383
192,531
253,304
310,005
245,462
209,837
215,756
216,821
222,731
676,301
432,119
385,549
385,549432,119676,301222,731216,821215,756209,837245,462310,005253,304192,531190,383232,869263,579239,400232,900170,285250,400131,529103,73858,24434,78328,15024,76127,80028,50020,20013,50018,90013,50011,1006,8005,7004,1002,9002,700
       Short-term Debt 
1,200
1,100
2,000
2,300
3,000
5,500
7,500
10,300
5,000
9,000
13,700
16,600
11,396
8,491
2,221
10,272
43,544
81,905
107,277
107,277
140,340
130,004
147,754
140,340
17,073
11,330
11,974
912
-60,184
-52,398
-3,228
16,950
1,514
1,689
2,204
1,950
1,9502,2041,6891,51416,950-3,228-52,398-60,18491211,97411,33017,073140,340147,754130,004140,340107,277107,27781,90543,54410,2722,2218,49111,39616,60013,7009,0005,00010,3007,5005,5003,0002,3002,0001,1001,200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,664
912
0
0
0
0
0
0
0
0
0000000091218,66400000000000000000000000000
       Accounts payable 
0
0
0
0
3,900
5,500
5,600
7,600
8,400
10,300
14,000
10,000
5,376
8,916
26,552
25,216
26,148
17,845
20,527
63,008
20,326
25,877
115,825
92,529
173,310
181,201
241,330
309,093
245,462
209,837
25,697
35,060
28,858
61,166
68,232
68,485
68,48568,23261,16628,85835,06025,697209,837245,462309,093241,330181,201173,31092,529115,82525,87720,32663,00820,52717,84526,14825,21626,5528,9165,37610,00014,00010,3008,4007,6005,6005,5003,9000000
       Other Current Liabilities 
1,500
1,800
2,100
3,400
-100
100
400
1,000
100
900
800
1,200
7,989
3,525
6,010
22,756
24,823
50,601
42,481
-31,387
62,760
65,941
-462
-5,586
-641
-351
-19,917
-79
59,385
52,231
190,059
155,372
192,122
605,863
355,895
314,211
314,211355,895605,863192,122155,372190,05952,23159,385-79-19,917-351-641-5,586-46265,94162,760-31,38742,48150,60124,82322,7566,0103,5257,9891,2008009001001,000400100-1003,4002,1001,8001,500
   > Long-term Liabilities 
3,100
3,500
3,400
3,600
2,600
4,000
2,700
2,000
11,900
15,300
17,200
17,900
25,496
41,914
53,839
51,305
163,674
196,504
0
171,861
0
0
111,328
97,246
34,399
23,144
10,479
10,357
5,427
6,110
7,055
7,383
8,763
35,115
32,799
19,106
19,10632,79935,1158,7637,3837,0556,1105,42710,35710,47923,14434,39997,246111,32800171,8610196,504163,67451,30553,83941,91425,49617,90017,20015,30011,9002,0002,7004,0002,6003,6003,4003,5003,100
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,976
0
0
0
0
0
0
0
0
000000004,976000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,164
1,145
1,398
1,857
2,442
4,931
15,435
15,299
7,666
7,591
8,576
4,934
3,996
2,852
4,726
5,427
6,110
7,055
7,383
7,610
33,788
28,841
0
028,84133,7887,6107,3837,0556,1105,4274,7262,8523,9964,9348,5767,5917,66615,29915,4354,9312,4421,8571,3981,1451,1640000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
1,901
2,232
2,114
3,228
0
0
0
0
0
000003,2282,1142,2321,9012800000000000000000000000000
> Total Stockholder Equity
1,500
1,500
2,100
1,900
4,800
10,000
17,600
21,800
24,100
26,300
27,300
28,800
40,552
50,214
218,364
269,137
347,400
368,120
236,865
236,865
153,238
164,217
49,783
153,238
567,264
886,347
1,015,507
1,411,719
1,931,142
2,067,494
2,205,158
1,905,536
2,103,862
1,703,649
1,711,443
1,730,858
1,730,8581,711,4431,703,6492,103,8621,905,5362,205,1582,067,4941,931,1421,411,7191,015,507886,347567,264153,23849,783164,217153,238236,865236,865368,120347,400269,137218,36450,21440,55228,80027,30026,30024,10021,80017,60010,0004,8001,9002,1001,5001,500
   Common Stock
0
0
0
0
0
0
0
0
0
0
700
700
680
680
700
680
680
680
680
679
680
680
680
680
679
680
680
680
680
680
680
680
679
679
680
680
6806806796796806806806806806806806796806806806806796806806806807006806807007000000000000
   Retained Earnings 
-600
-500
-700
-900
0
900
1,100
4,500
6,500
8,700
10,100
12,400
17,943
27,970
54,000
98,519
159,674
170,749
-46,000
61,992
-95,500
-65,000
-128,673
-95,515
295,787
609,245
969,632
1,453,889
1,994,821
2,451,177
2,662,327
2,481,029
2,725,270
2,338,617
2,388,691
2,414,136
2,414,1362,388,6912,338,6172,725,2702,481,0292,662,3272,451,1771,994,8211,453,889969,632609,245295,787-95,515-128,673-65,000-95,50061,992-46,000170,749159,67498,51954,00027,97017,94312,40010,1008,7006,5004,5001,1009000-900-700-500-600
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
262,445
262,445
262,445
262,445
262,445
262,445
0
0
0
000262,445262,445262,445262,445262,445262,445000000000000000000000000000
   Treasury Stock000-721,494-694,510-610,009-498,675-203,778-194,328-194,328-1,329-1,329-1,329-1,329-1,329-1,361-1,388-1,387-1,348-1,348-1,288-1,28800000000000000
   Other Stockholders Equity 
2,100
2,000
2,800
2,800
0
9,100
16,500
17,300
17,600
17,600
18,100
19,100
23,800
24,300
168,900
172,296
181,351
183,214
0
162,383
0
0
163,670
220,453
252,248
259,679
68,091
68,117
58,667
-236,230
-347,564
-432,065
-459,050
-484,026
-508,963
-508,962
-508,962-508,963-484,026-459,050-432,065-347,564-236,23058,66768,11768,091259,679252,248220,453163,67000162,3830183,214181,351172,296168,90024,30023,80019,10018,10017,60017,60017,30016,5009,10002,8002,8002,0002,100



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue572,952
Cost of Revenue-304,629
Gross Profit268,323268,323
 
Operating Income (+$)
Gross Profit268,323
Operating Expense-250,609
Operating Income17,71417,714
 
Operating Expense (+$)
Research Development52,243
Selling General Administrative85,086
Selling And Marketing Expenses113,280
Operating Expense250,609250,609
 
Net Interest Income (+$)
Interest Income20,850
Interest Expense-17,686
Other Finance Cost-17,686
Net Interest Income20,850
 
Pretax Income (+$)
Operating Income17,714
Net Interest Income20,850
Other Non-Operating Income Expenses0
Income Before Tax (EBT)38,213-2,785
EBIT - interestExpense = 28
38,213
43,131
Interest Expense17,686
Earnings Before Interest and Taxes (EBIT)17,71455,899
Earnings Before Interest and Taxes (EBITDA)52,654
 
After tax Income (+$)
Income Before Tax38,213
Tax Provision-12,768
Net Income From Continuing Ops25,44525,445
Net Income25,445
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses555,238
Total Other Income/Expenses Net20,499-20,850
 

Technical Analysis of Taro
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Taro. The general trend of Taro is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Taro's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Taro Pharmaceutical Industries Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 42.48 < 42.49 < 45.76.

The bearish price targets are: 41.85 > 40.80 > 40.67.

Tweet this
Taro Pharmaceutical Industries Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Taro Pharmaceutical Industries Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Taro Pharmaceutical Industries Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Taro Pharmaceutical Industries Ltd. The current macd is 0.05771354.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Taro price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Taro. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Taro price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Taro Pharmaceutical Industries Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTaro Pharmaceutical Industries Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Taro Pharmaceutical Industries Ltd. The current adx is 11.60.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Taro shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Taro Pharmaceutical Industries Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Taro Pharmaceutical Industries Ltd. The current sar is 41.94.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Taro Pharmaceutical Industries Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Taro Pharmaceutical Industries Ltd. The current rsi is 56.98. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Taro Pharmaceutical Industries Ltd Daily Relative Strength Index (RSI) ChartTaro Pharmaceutical Industries Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Taro Pharmaceutical Industries Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Taro price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Taro Pharmaceutical Industries Ltd Daily Stochastic Oscillator ChartTaro Pharmaceutical Industries Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Taro Pharmaceutical Industries Ltd. The current cci is 143.01.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Taro Pharmaceutical Industries Ltd Daily Commodity Channel Index (CCI) ChartTaro Pharmaceutical Industries Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Taro Pharmaceutical Industries Ltd. The current cmo is 20.89.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Taro Pharmaceutical Industries Ltd Daily Chande Momentum Oscillator (CMO) ChartTaro Pharmaceutical Industries Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Taro Pharmaceutical Industries Ltd. The current willr is -14.0625.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Taro Pharmaceutical Industries Ltd Daily Williams %R ChartTaro Pharmaceutical Industries Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Taro Pharmaceutical Industries Ltd. The current atr is 0.26785554.

Taro Pharmaceutical Industries Ltd Daily Average True Range (ATR) ChartTaro Pharmaceutical Industries Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Taro Pharmaceutical Industries Ltd. The current obv is 2,303,346.

Taro Pharmaceutical Industries Ltd Daily On-Balance Volume (OBV) ChartTaro Pharmaceutical Industries Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Taro Pharmaceutical Industries Ltd. The current mfi is 54.22.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Taro Pharmaceutical Industries Ltd Daily Money Flow Index (MFI) ChartTaro Pharmaceutical Industries Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Taro Pharmaceutical Industries Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Taro Pharmaceutical Industries Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Taro Pharmaceutical Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.981
Ma 20Greater thanMa 5042.189
Ma 50Greater thanMa 10042.128
Ma 100Greater thanMa 20041.789
OpenGreater thanClose42.340
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Taro with someone you think should read this too:
  • Are you bullish or bearish on Taro? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Taro? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Taro Pharmaceutical Industries Ltd

I send you an email if I find something interesting about Taro Pharmaceutical Industries Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Taro Pharmaceutical Industries Ltd.

Receive notifications about Taro Pharmaceutical Industries Ltd in your mailbox!